SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026
January 2, 2026
 · 
9 min read
Press Releases
PharmaTher CEO Publishes Letter to Shareholders
January 2, 2026
 · 
7 min read
Press Releases
Izotropic Announces AGM Results
January 2, 2026
 · 
3 min read
Press Releases
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
January 2, 2026
 · 
6 min read
Press Releases
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea
Expansion builds on newly granted South Korean patent, rising local demand and following the launch of digitally connected “VIVI Cap Smart” device
January 2, 2026
 · 
6 min read
Press Releases
BioMark: 2025 Achievements & 2026 Vision
Celebrating A Year of Extraordinary Achievement
January 2, 2026
 · 
7 min read
Press Releases
BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors
Expanding U.S. market access with an experienced technology investor and AI-driven growth strategist
January 2, 2026
 · 
3 min read
Press Releases
CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways
January 2, 2026
 · 
4 min read
Press Releases
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering
Integrated smart technology builds on TempraMed’s proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medication
January 2, 2026
 · 
6 min read
Press Releases
Bioprinting and Bio-inks: Shifting Paradigms in Regenerative Medicine and Future Economic Outlook, Commentary by unexakorea
January 2, 2026
 · 
1 min read
Press Releases
AINGENS MACg Slide Generator
January 2, 2026
 · 
1 min read
Press Releases
ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
January 1, 2026
 · 
3 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 31, 2025
January 1, 2026
 · 
1 min read
Press Releases
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
January 1, 2026
 · 
8 min read
Press Releases
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
January 1, 2026
 · 
5 min read
Press Releases
Alvotech Secures Term Loan Facility of USD 100 Million
January 1, 2026
 · 
5 min read
Press Releases
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
January 1, 2026
 · 
7 min read
Press Releases
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
January 1, 2026
 · 
5 min read
Press Releases
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
January 1, 2026
 · 
3 min read
Press Releases
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 1, 2026
 · 
4 min read
Press Releases
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
January 1, 2026
 · 
5 min read
Press Releases
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins
January 1, 2026
 · 
7 min read
Press Releases
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
January 1, 2026
 · 
3 min read
Press Releases
Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent
January 1, 2026
 · 
2 min read
Press Releases
Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting
December 9, 2025
 · 
11 min read
Press Releases
Genetix Presents Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation at the 67th American Society of Hematology (ASH) Annual Meeting
December 9, 2025
 · 
15 min read
Press Releases
MJFF Initiates Funding for Emerging Therapeutic Targets in Parkinson’s Disease
December 9, 2025
 · 
4 min read
Press Releases
Opna Bio Showcases Multi-Functional Degraders with Potent Anti-Myeloma Activity and Encouraging Spleen Reductions in Patients with Myelofibrosis Treated with OPN-2853 and Ruxolitinib
December 9, 2025
 · 
4 min read
Press Releases
MaaT Pharma Presents Pivotal ARES Phase 3 Results for MaaT013 (Xervyteg®) in Acute GvHD at ASH 2025 Annual Congress and Announces 54% 1-Year Overall Survival
December 9, 2025
 · 
7 min read
Press Releases
Abcuro Presents Interim Phase 1 Data Evaluating Ulviprubart in Patients with T Cell Large Granular Lymphocytic Leukemia at the 67th American Society of Hematology Annual Meeting
December 9, 2025
 · 
4 min read
Press Releases
Lilly declares first-quarter 2026 dividend
December 9, 2025
 · 
2 min read
Press Releases
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
December 9, 2025
 · 
2 min read
Press Releases
SABCS 2025: REVEAL GENOMICS Presents Major Advance in Predicting Brain Metastasis in HER2+ Breast Cancer
December 9, 2025
 · 
7 min read
Press Releases
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
December 9, 2025
 · 
4 min read
Load More